Spero Therapeutics and the Gates Foundation Collaborate on Tuberculosis Treatment

Cambridge, Mass.-based Spero Therapeutics and the Bill & Melinda Gates Foundation have teamed up to take on the challenge of a lung infection that has been designated as a critical concern by the World Health Organization.

Spero and the Gates Foundation will work together to tackle lung infections caused by Mycobacterium tuberculosis (Mtb).